Shuchi Nahar's Weekend Blog!

  India's Biotechnology Industry Size, Opportunities, and Investments  Twitter Handle: @shuchi_nahar Link to my previous biotechnology blog: https://myweekendspot.blogspot.com/2021/05/biotechnology-way-towards-bio-based.html India’s Biotechnology Industry The Indian biotechnology industry amounted to US$ 63 billion in 2019 and is forecast to reach US$ 150 billion by 2025, with a CAGR of 16.4%. By 2025, the contribution of the Indian biotechnology industry in the global biotechnology market is expected to grow to 19% from 3% in 2017. Bio-services, which accounted for 15% of the biotechnology industry in India, is becoming a leading destination for clinical trials, contract research, and manufacturing activities in the country. • In FY20, the sector grew 15% year on year • By FY24, the contribution of the Indian biotechnology industry in the global biotechnology market is expected to grow to 19% from 3% in FY18 • India has over 4237+ biotech startups and is expected to have ...

Biotechnology – The way towards a Biobased economy Biotechnology companies have developed to form backbone support to the economy of the nation. The bio-economy includes all activities related to the production of biomass and the ways in which the biomass and its residues can be used subsequently. Introduction to Biotechnology There is growing consumer demand for natural products, low-carbon solutions, and bio-based innovation. Industrial biotechnology is a key enabling technology for delivering these solutions. At the same time, there is a huge opportunity for biotechnology aligned with Agriculture & chemical sectors. However, in the modern financial world, biotechnology companies comprise an industry sector collectively known as the biotech. The research, develop, and produce a wide variety of commercial products, though most of them focus on medical or agricultural applications. Green Biotechnology (Agricultural Biotechnology) – Huge growth opportunities ahead Green Biot...

Dishman Carbogen Amcis  - Company Overview Twitter Handle: @shuchi_nahar Company Profile   Incorporated in 1983, Dishman Carbogen  Amcis  Limited (DCAL) started out as a manufacturer of quaternary ammonium and phosphate compounds. Having ventured into the CRAMS space in India, the company soon became one of the fastest growing companies. Today, company is a leading global outsourcing partner for the pharmaceutical industry,  offering  a portfolio of development, scale-up, and manufacturing services.   Company is a fully integrated CRAMS player working with global pharmaceutical innovators. Company has a global presence with development and manufacturing facilities across Europe, India, and China. Company provides end-to-end, integrated, high-value, niche CRAMS  offering , right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to i...